JP MORGAN/CALL/CORTEVA/75/0.1/17.01.25 Stock

Warrant

DE000JS551J3

Real-time Bid/Ask 11:32:51 2024-05-27 EDT
0.16 EUR / 0.24 EUR +25.00% Intraday chart for JP MORGAN/CALL/CORTEVA/75/0.1/17.01.25
1 month-33.33%
3 months-36.00%
Date Price Change
24-05-27 0.16 0.00%
24-05-24 0.16 -15.79%
24-05-23 0.19 0.00%
24-05-22 0.19 0.00%
24-05-21 0.19 +5.56%

Delayed Quote Börse Stuttgart

Last update May 27, 2024 at 05:26 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CORTEVA, INC.
Issuer J.P. Morgan
WKN JS551J
ISINDE000JS551J3
Date issued 2023-02-10
Strike 75 $
Maturity 2025-01-17 (235 Days)
Parity 10 : 1
Emission price 0.64
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.1
Lowest since issue 0.082
Delta0.24x
Omega 6.156
Premium39.02x
Gearing25.57x
Moneyness 0.7401
Difference Strike 19.49 $
Difference Strike %+25.99%
Spread 0.08
Spread %33.33%
Theoretical value 0.2000
Implied Volatility 39.78 %
Total Loss Probability 84.53 %
Intrinsic value 0.000000
Present value 0.2000
Break even 77.17 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Corteva, Inc. specializes in the manufacturing and marketing of agricultural and phytosanitary products. Net sales break down by activity as follows: - production of seed and grain (51.4%): mainly corn seeds (66.2% of net sales) and soybeans (20.2%); - manufacture of crop protection products (48.6%): herbicides (54.2% of net sales), insecticides (21.6%), fungicides (17.1%) and other 7.1%). At the end of 2022, the group had 85 production sites worldwide. Net sales are distributed geographically as follows: the United States and Canada (47.5%), Latin America (25.5%), Europe/Middle East/Africa (18.6%), and Asia/Pacific (8.4%).
Sector
-
More about the company

Ratings for Corteva, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Corteva, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
55.51 USD
Average target price
63.77 USD
Spread / Average Target
+14.88%
Consensus